Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
923.1 INR | -2.05% | -2.83% | +21.56% |
May. 30 | Alembic Pharmaceuticals Gets US FDA Final Nod for Sacubitril and Valsartan Tablets | MT |
May. 09 | Transcript : Alembic Pharmaceuticals Limited, Q4 2024 Earnings Call, May 09, 2024 |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Neutral | Bullish | Bullish |
Resistance | 1,024.30 | 1,079.55 | 1,055.00 |
Spread/Res. | -9.88% | -14.49% | -12.50% |
Spread/Supp. | -0.85% | +4.01% | +15.26% |
Support | 931.05 | 887.55 | 800.90 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- APLLTD Stock
- Charts Alembic Pharmaceuticals Limited